Evidence-based approaches to other symptoms in advanced cancer

Cancer Journal

Volumn 16, Issue 5, 2010, Pages 507-513

  Dy, Sydney Morss ^a   Apostol, Colleen C ^b  

^a JohnsHopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

anorexia; Dyspnea; fatigue; insomnia; nausea; sleep disturbances; vomiting

Indexed keywords

ANALGESIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CODEINE; CYCLIZINE; DEXAMETHASONE; DOPAMINE RECEPTOR BLOCKING AGENT; DRONABINOL; DROPERIDOL; FLUOXYMESTERONE; FUROSEMIDE; HELIOX; MEGESTROL ACETATE; METHYLPHENIDATE; METOCLOPRAMIDE; OCTREOTIDE; ONDANSETRON; OPIATE; PHENOTHIAZINE; PROCHLORPERAZINE; PROMETHAZINE; SCLEROSING AGENT; SCOPOLAMINE; SEROTONIN 3 ANTAGONIST; TALC; TROPISETRON; UNINDEXED DRUG;

ADVANCED CANCER; ANOREXIA; CLINICAL TRIAL; COGNITIVE THERAPY; CONFUSION; CONSTIPATION; DELIRIUM; DISTRESS SYNDROME; DROWSINESS; DRUG DOSE ESCALATION; DRUG MEGADOSE; DYSPNEA; ENTERIC FEEDING; EVIDENCE BASED MEDICINE; FATIGUE; HUMAN; INSOMNIA; INTESTINE OBSTRUCTION; INTUBATION; NAUSEA; NAUSEA AND VOMITING; PARENTERAL NUTRITION; PLEURA EFFUSION; PLEURODESIS; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RESPIRATION DEPRESSION; REVIEW; RISK BENEFIT ANALYSIS; SLEEP DISORDER; SYMPTOM; SYSTEMATIC REVIEW; VOMITING;

ANOREXIA; CACHEXIA; DELIRIUM; DYSPNEA; EVIDENCE-BASED MEDICINE; FATIGUE; HUMANS; INTESTINAL OBSTRUCTION; NAUSEA; NEOPLASMS; PLEURAL EFFUSION; SLEEP DISORDERS; VOMITING;

EID: 77958123118     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e3181f45877     Document Type: Review

References (56)

1. Lorenz KA, Dy SM, Naeim A, et al. Quality measures for supportive cancer care: the Cancer Quality-ASSIST (Assessing Symptoms Side Effects and Indicators of Supportive Treatment) project. J Pain Symptom Manage. 2009;37:943-964.
2. Dy SM, Lorenz KA, Naeim A, et al. Evidence-based recommendations for cancer fatigue, anorexia, depression, and dyspnea. J ClinOncol. 2008; 26:3886-3895.
3. Kvale PA, Simoff M, Prakash UB. Lung cancer. Palliative care. Chest. 2003;123:284SY311S.
4. Dong X, Abernethy AP. Management of dyspnea in advanced lung cancer: recent data and emerging concepts. Curr Opin Support Palliat Care. 2010;4:85-91.
5. Jennings AL, Davies AN, Higgins JP, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57:939-944. (Pubitemid 35316271)
6. Ben-Aharon I, Gafter-Gvili A, Paul M, et al. Interventions for alleviating cancer-related dyspnea: a systematic review. J Clin Oncol. 2008;26: 2396-2404.
7. Brown SJ, Eichner SF, Jones JR. Nebulized morphine for relief of dyspnea due to chronic lung disease. Ann Pharmacother. 2005;39: 1088-1092.
8. Charles MA, Reymond L, Israel F. Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline. J Pain Symptom Manage. 2008;36:29-38.
9. Clemens KE, Quednau I, Klaschik E. Is there a higher risk of respiratory depression in opioid-naive palliative care patients during symptomatic therapy of dyspnea with strong opioids? J Palliat Med. 2008;11:204-216. (Pubitemid 351374202)
10. Simon ST, Higginson IJ, Booth S, et al. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev. 2010:CD007354.
11. Viola R, Kiteley C, Lloyd NS, et al. Supportive Care Guidelines Group of the Cancer Care Ontario Program in Evidence-Based Care. The management of dyspnea in cancer patients: a systematic review. Support Care Cancer. 2008;16:329-337.
12. Ahmedzai SH, Laude E, Robertson A, et al. A double-blind, randomised, controlled phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion. Br J Cancer. 2004;90:366-371. (Pubitemid 38250630)
13. Sola I, Thompson E, Subirana M, et al. Non-invasive interventions for improving well-being and quality of life in patients with lung cancer. Cochrane Database Syst Rev. 2004;4:CD004282.
14. Zhao I, Yates P. Nonpharmacological interventions for breathlessness management in patients with lung cancer: a systematic review. Palliat Med. 2008;22:693-701.
15. Galbraith S, Fagan P, Perkins P, et al. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage. 2010;39:831-838.
16. Lacasse Y, Martin S, Lasserson TJ, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease: a systematic review. Eura Medicophys. 2007;43:475-485.
17. Bausewein C, Booth S, Gysels M, et al. Nonpharmacological interventions for breathlessness in advanced stages of malignant and nonmalignant diseases. Cochrane Database Syst Rev. 2008;2:CD005623. (Pubitemid 351807383)
18. Antunes G, Neville E, Duffy J, et al. BTS guidelines for the management of malignant pleural effusions. Thorax. 2003;58:ii29Yii38. (Pubitemid 36561106)
19. Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev. 2004;1:CD002916.
20. Davis MP, Hallerberg G, Palliative Medicine Study Group of the Multinational Association of Supportive Care in Cancer. A systematic review of the treatment of nausea and/or vomiting in cancer unrelated to chemotherapy or radiation. J Pain Symptom Manage. 2010;39:756-767.
21. Bruera E, Moyano JR, Sala R, et al Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial. J Pain Symptom Manage. 2004;28:381-388. (Pubitemid 39313167)
22. Wood GJ, Shega JW, Lynch B, et al. Management of intractable nausea and vomiting in patients at the end of life. JAMA. 2007;298:1196-2007.
23. McNicol E, Horowicz-Mehler N, Fisk RA, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain. 2003;4:231-256. (Pubitemid 36807905)
24. Ezzo J, Streitberger K, Schneider A. Cochrane systematic reviews examine P6 acupuncture-point stimulation for nausea and vomiting. J Altern Complement Med. 2006;12:489-495. (Pubitemid 44061507)
25. Ripamonti C, Twycross R, Baines M, et al. Working Group of the European Association for Palliative Care. Clinical-practice recommendations for the management of bowel obstruction in patients with endstage cancer. Support Care Cancer. 2001;9:223-233. (Pubitemid 32537280)
26. Tilney HS, Lovegrove RE, Purkayastha S, et al. Comparison of colonic stenting and open surgery for malignant large bowel obstruction. Surg Endosc. 2007;23:225-233. (Pubitemid 46122408)
27. Dormann A, Meisner S, Verin N, et al. Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy. 2004;36:543-550. (Pubitemid 38811624)
28. Feuer DJ, Broadley KE, Shepherd JH, et al. Systematic reviewof surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. The Systematic Review Steering Committee. Gynecol Oncol. 1999;75:313-322.
29. Mercadante S, Casuccio A, Mangione S. Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review. J Pain Symptom Manage. 2007;33:217-223. (Pubitemid 46201883)
30. Laval G, Girardier J, Lassauniere JM, et al. The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction? Palliat Med. 2000;14:3-10. (Pubitemid 30095220)
31. Feuer DJ, Broadley KE. Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev. 2009;2:CD001219.
32. Hardy J, Ling J, Mansi J, et al. Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction. Palliat Med. 1998;12:437-442. (Pubitemid 28528912)
33. Campagnutta E, Cannizzaro R, Gallo A, et al. Palliative treatment of upper intestinal obstruction by gynecological malignancy: the usefulness of percutaneous endoscopic gastrostomy. Gynecol Oncol. 1996;62: 103-105. (Pubitemid 26234553)
34. Garg S, Yoo J, Winquist E. Nutritional support for head and neck cancer patients receiving radiotherapy: a systematic review. Support Care Cancer. 2010;18:667-677.
35. Yavuzsen T, Davis MP,Walsh D, et al. Systematic reviewof the treatment of cancer-associated anorexia and weight loss. J Clin Oncol. 2005;23: 8500-8511. (Pubitemid 46260247)
36. Mantovani G, Macciò A, Madeddu C, et al. Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia. Oncologist. 2010;15:200-211.
37. Navari RM, Brenner MC. Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial. Support Care Cancer. 2010;18:951-956.
38. Riechelmann RP, Burman D, Tannock IF, et al. Phase II trial of mirtazapine for cancer-related cachexia and anorexia. Am J Hosp Palliat Care. 2010;27:106-110.
39. Dy SM. Enteral and parenteral nutrition in terminally ill cancer patients: a review of the literature. Am J Hosp Palliat Care. 2006;23:369-377.
40. Hasenberg T, Essenbreis M, Herold A, et al. Early supplementation of parenteral nutrition is capable of improving quality of life, chemotherapyrelated toxicity and body composition in patients with advanced colorectal carcinoma undergoing palliative treatment. Results from a prospective, randomized clinical trial. Colorectal Dis. Epub November 6, 2009.
41. August DA, Huhmann MB, American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr. 2009; 33:472-500.
42. Goedendorp MM, Gielissen MF, Verhagen CA, et al. Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev. 2009;1:CD006953.
43. National Comprehensive Cancer Network. Cancer fatigue. Available at: http://www.nccn.org. Accessed August 13, 2010.
44. Cramp F, Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2008;2:CD006145. (Pubitemid 351807301)
45. Velthuis MJ, Agasi-Idenburg SC, Aufdemkampe G, et al. The effect of physical exercise on cancer-related fatigue during cancer treatment: a meta-analysis of randomised controlled trials. Clin Oncol (R Coll Radiol). 2010;22:208-221.
46. Minton O, Stone P, Richardson A, et al. Drug therapy for the management of cancer related fatigue. Cochrane Database Syst Rev. 2008; 1:CD006704. (Pubitemid 351807546)
47. Lower EE, Fleishman S, Cooper A, et al. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. J Pain Symptom Manage. 2009;38:650-662.
48. Mar Fan HG, Clemons M, XuW, et al. A randomised, placebo-controlled, double-blind trial of the effects of D-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer. 2008;16:577-583.
49. Berger AM. Update on the state of the science: sleep-wake disturbances in adult patients with cancer. Oncol Nurs Forum. 2009;36: E165YE177.
50. Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4:487-504.
51. Clark J, Cunningham M, McMillan S, et al. Sleep-wake disturbances in people with cancer part II: evaluating the evidence for clinical decision making. Oncol Nurs Forum. 2004;31:747-771.
52. Glass J, Lanctot KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005; 331:1169. (Pubitemid 41689427)
53. Buscemi N, Vandermeer B, Friesen C, et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med. 2007;22:1335-1350. (Pubitemid 47247294)
54. Breitbart W, Tremblay A, Gibson C. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics. 2002;43:175-182. (Pubitemid 34522527)
55. Lonergan E, Britton AM, Luxenberg J, et al. Antipsychotics for delirium. Cochrane Database Syst Rev. 2007;2:CD005594 (Pubitemid 351805712)
56. Lacasse H, Perreault MM, Williamson DR. Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients. Ann Pharmacother. 2006;40:1966-1973. (Pubitemid 44747466)